CN101194965B - 一种治疗头痛的咀嚼片及其制备方法 - Google Patents
一种治疗头痛的咀嚼片及其制备方法 Download PDFInfo
- Publication number
- CN101194965B CN101194965B CN2006101299552A CN200610129955A CN101194965B CN 101194965 B CN101194965 B CN 101194965B CN 2006101299552 A CN2006101299552 A CN 2006101299552A CN 200610129955 A CN200610129955 A CN 200610129955A CN 101194965 B CN101194965 B CN 101194965B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- add
- radix
- ramulus uncariae
- uncariae cum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010019233 Headaches Diseases 0.000 title claims abstract description 23
- 231100000869 headache Toxicity 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title abstract description 8
- 230000018984 mastication Effects 0.000 title 1
- 238000010077 mastication Methods 0.000 title 1
- 241000218176 Corydalis Species 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000007910 chewable tablet Substances 0.000 claims abstract description 14
- 229940068682 chewable tablet Drugs 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 66
- 239000000843 powder Substances 0.000 claims description 23
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 21
- 241000217407 Margaritifera Species 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000007796 conventional method Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 230000006837 decompression Effects 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 41
- 229940079593 drug Drugs 0.000 abstract description 15
- 239000000284 extract Substances 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 7
- 239000002552 dosage form Substances 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 229940095559 cafergot Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- CJMJLDQKTOJACI-SEUSHGJOSA-N chembl2448612 Chemical compound OC(=O)C(O)C(O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-SEUSHGJOSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- -1 electuary Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940023488 pill Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101299552A CN101194965B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的咀嚼片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101299552A CN101194965B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的咀嚼片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101194965A CN101194965A (zh) | 2008-06-11 |
CN101194965B true CN101194965B (zh) | 2013-06-05 |
Family
ID=39545711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101299552A Active CN101194965B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的咀嚼片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101194965B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103652916B (zh) * | 2013-12-11 | 2015-08-12 | 罗永祺 | 一种枸杞子山药咀嚼片及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1073874A (zh) * | 1992-11-14 | 1993-07-07 | 中国人民解放军第二五四医院 | 活血清脑冲剂 |
CN1500513A (zh) * | 2002-11-15 | 2004-06-02 | 梅宗汉 | 治疗头痛的中药冲剂 |
CN1593634A (zh) * | 2004-06-25 | 2005-03-16 | 张晴龙 | 一种养血清脑口腔崩解片及其制备方法 |
-
2006
- 2006-12-08 CN CN2006101299552A patent/CN101194965B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1073874A (zh) * | 1992-11-14 | 1993-07-07 | 中国人民解放军第二五四医院 | 活血清脑冲剂 |
CN1500513A (zh) * | 2002-11-15 | 2004-06-02 | 梅宗汉 | 治疗头痛的中药冲剂 |
CN1593634A (zh) * | 2004-06-25 | 2005-03-16 | 张晴龙 | 一种养血清脑口腔崩解片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101194965A (zh) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101987122B (zh) | 一种用于缓解人体疼痛的药物及其制备方法 | |
CN101987123B (zh) | 一种用于缓解颈肩、腰腿、关节、肌肉疼痛的药物及其制备方法 | |
CN101632737A (zh) | 一种用于缓解人体疼痛的药物及其制备方法 | |
CN101019975A (zh) | 一种治疗骨折的中药组合物及其制备方法 | |
CN1765392A (zh) | 一种补血调经,止血安胎的中药复方制剂及其制备方法 | |
CN101347548A (zh) | 一种治疗头痛的口服制剂及制备方法 | |
CN1872217B (zh) | 一种治疗头痛的药物及其制备方法 | |
CN101194964B (zh) | 一种治疗头痛的包衣片剂及其制备方法 | |
CN101194945B (zh) | 一种治疗头痛的片剂及其制备方法 | |
CN101194959B (zh) | 一种治疗头痛的胶囊及其制备方法 | |
CN1709326A (zh) | 一种治疗乳腺增生疾病的浓缩丸制备方法 | |
CN101194965B (zh) | 一种治疗头痛的咀嚼片及其制备方法 | |
CN111358906B (zh) | 一种适用于外感症的中药组合物 | |
CN101194958B (zh) | 一种治疗头痛的煎膏剂的制备方法 | |
CN1413697A (zh) | 中药六味地黄制剂的生产方法 | |
CN101279070A (zh) | 一种温肾活血、通经活络的药物组合及其制备方法 | |
CN102247503B (zh) | 治疗下肢发冷的中药外洗泡腾片及其制备方法 | |
CN101194963B (zh) | 一种治疗头痛的药物的制备方法 | |
CN105250427A (zh) | 一种治疗心脏疾病的药物组合物 | |
CN101264270A (zh) | 一种治疗子宫内膜异位症的中药组合物及其制备方法 | |
CN101194967B (zh) | 一种治疗头痛的舌下口含片及其制备方法 | |
CN101194962B (zh) | 一种治疗头痛的丸剂及其制备方法 | |
CN104147229B (zh) | 一种治疗女性更年期综合征肾阴阳两虚型的中药复方制剂 | |
CN101194940A (zh) | 治疗牙痛的消炎药物及其制作方法 | |
CN101194966B (zh) | 一种治疗头痛的口含片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Applicant after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Applicant before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN TASLY PHARMACEUTICAL CO., LTD. TO: TASLY PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |